Capital Fund Management (CFM)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Capital Fund Management (CFM)’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,090	Closed	-$229K	–	1752
2021 Q2	$229K	Buy	+19,090	New	+$216K	﹤0.01%	1383
2020 Q2	–	Sell	-25,822	Closed	-$164K	–	1505
2020 Q1	$164K	Buy	+25,822	New	+$192K	﹤0.01%	1443
2019 Q2	–	Sell	-54,606	Closed	-$521K	–	1887
2019 Q1	$521K	Buy	54,606 +24,370	+81%	+$249K	﹤0.01%	1238
2018 Q4	$347K	Sell	30,236 -243,348	-89%	-$3.02M	﹤0.01%	1539
2018 Q3	$4.64M	Buy	+273,584	New	+$4.16M	0.03%	799
2014 Q3	–	Sell	-132,411	Closed	-$2.02M	–	1785
2014 Q2	$2.02M	Buy	+132,411	New	+$1.9M	0.02%	716

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital Fund Management (CFM)'s SGMO Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2021, closing a stake of 19,090 shares — an estimated $229K sold.

Capital Fund Management (CFM) first reported a position in SGMO in Q2 2014 and held it in 6 quarters. The position peaked at $4.64M in Q3 2018. 193 funds tracked by Wall St. Rank hold SGMO as of Q3 2021.

Capital Fund Management (CFM) reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 19,090 SANGAMO THERAPEUTICS INC shares in Q3 2021, an estimated $229K.
Capital Fund Management (CFM) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 6 quarters.
Capital Fund Management (CFM)'s SANGAMO THERAPEUTICS INC position peaked at $4.64M in Q3 2018.
193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.